Bloodless Total Hip Arthroplasty in Jehovah’s Witness Patients: Contemporary Strategies and Outcomes
The Journal of Arthroplasty · 2025
DOI: 10.1016/j.arth.2024.09.035 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Arthroplasty, 2025. Verfasst von Victor Shen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic Surgery, University of South Florida Health Morsani College of Medicine, Tampa, Florida. Hauptthemen laut MEDLINE: Jehovah's Witnesses, Arthroplasty, Replacement, Hip, Blood Loss, Surgical, Bloodless Medical and Surgical Procedures. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Reported blood transfusion rates in total hip arthroplasty (THA) range between 3 and 22%. Jehovah's Witnesses (JW) do not accept blood transfusions and make conscience decisions to accept blood derivatives. This study reports on strategies and outcomes for bloodless THA. METHODS: All JW patients undergoing primary THA at our institution between 2011 and 2022 were included in this study (94 of 110 THA). The indications for THA were osteoarthritis (92%), femoral neck fracture (6%), rheumatoid arthritis (1%), and failed open reduction and internal fixation (1%). Strategies used to optimize outcomes included erythropoietin, tranexamic acid, cell savers, intrailiac artery tourniquets, and minimizing phlebotomy. RESULTS: The mean estimated blood loss was 201.2 ± 122.2 mL. Preoperative hemoglobin (Hgb) levels were 13.4 ± 1.4 g/dL, which decreased to 11.0 ± 1.3 g/dL on postoperative day 1 (POD1, P < 0.001), 10.3 ± 1.5 g/dL on POD2 (P = 0.001), and 9.8 ± 1.1 g/dL on POD3 (P = 0.171). The use of tranexamic acid significantly decreased Hgb drop on POD1 (P = 0.04). Subgroup analysis showed that preoperatively anemic patients (closed circuit, Hgb < 12 g/dL) had significantly less Hgb drop postoperatively (P = 0.003). No patients met the recommended transfusion threshold (Hgb < 7 g/dL). There were two 90-day readmissions due to falls. There was zero 90-day mortality. CONCLUSIONS: A THA can be safely performed on JW patients. Preoperatively anemic patients had a decreased Hgb drop postoperatively. JW patients make a conscious decision to accept blood derivatives, which may be present in medications including erythropoietin. We recommend maintaining an Hgb above 11 g/dL prior to surgery, as a Hgb drop of 3.1 g/dL can be expected. These findings highlight the efficacy of a multimodal approach to optimizing bloodless primary THAs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedic Surgery, University of South Florida Health Morsani College of Medicine, Tampa, Florida.
- Department of Orthopaedic Surgery, University of South Florida Health Morsani College of Medicine, Tampa, Florida; Foundation for Orthopaedic Research and Education, Tampa, Florida.
- Department of Orthopaedic Surgery, University of South Florida Health Morsani College of Medicine, Tampa, Florida; Florida Orthopaedic Institute, Temple Terrace, Florida.
Zitieren
APA
Shen, V., Salomon, K. I., Ohanisian, L. L., Simon, P., Miranda, M. A., & Bernasek, T. L. (2025). Bloodless Total Hip Arthroplasty in Jehovah’s Witness Patients: Contemporary Strategies and Outcomes. The Journal of Arthroplasty. https://doi.org/10.1016/j.arth.2024.09.035
Vancouver
Shen V, Salomon KI, Ohanisian LL, Simon P, Miranda MA, Bernasek TL. Bloodless Total Hip Arthroplasty in Jehovah’s Witness Patients: Contemporary Strategies and Outcomes. The Journal of Arthroplasty. 2025. doi:10.1016/j.arth.2024.09.035
BibTeX
@article{Shen2025,
author = {Shen, Victor and Salomon, Kevin I and Ohanisian, Levonti L and Simon, Peter and Miranda, Michael A and Bernasek, Thomas L},
title = {Bloodless Total Hip Arthroplasty in Jehovah’s Witness Patients: Contemporary Strategies and Outcomes},
journal = {The Journal of Arthroplasty},
year = {2025},
doi = {10.1016/j.arth.2024.09.035}
}
EUVIMED